Skip to main content

BeiGene Constructs Manufacturing and Clinical R&D Center

Published 8/23/2023
BeiGene - Manufacturing and Clinical R&D Cente
BeiGene - Manufacturing and Clinical R&D Center
BeiGene - Manufacturing and Clinical R&D Center

BeiGene is constructing a $700 million campus for biologics manufacturing and research in Hopewell, N.J. Sited on 42 acres at the Princeton West Innovation Campus, the next-generation complex will provide 400,000 sf of dedicated space for commercial-stage production of cancer therapies, with up to 16,000 liters of biologics capacity. A 100,000-sf lab building will house clinical R&D suites and collaborative office environments. As BeiGene's U.S. headquarters and flagship manufacturing facility, the highly flexible development will leverage universal design principles to create an adaptable, human-centric environment.

Integrated Project Services (IPS) is the lead architect and engineer for the project with Meyer as associate architect and interior designer. DPR Construction is the general contractor for the complex, which broke ground in April of 2022. Two of the structures will incorporate prefabricated modules that were created off-site and transported from the Port of Philadelphia. Completion is expected in mid-2024. Future plans for the campus include the addition of another 600,000 sf of leading-edge manufacturing and research space. 

Organization Project Role
Integrated Project Services
Lead Architect and Engineer
Meyer
Associate Architect and Interior Designer
DPR Construction, Inc.
General Contractor